CoChat
Sign Up
Cited by 365Neuroinflammation and Neurodegeneration MechanismsInflammasome and immune disordersNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 411 of the 414 references it cites were found in a registry or an index.

Microglia: Agents of the CNS Pro-Inflammatory Response

Open access
Rodríguez-Gómez, José A., Kavanagh, Edel, Engskog-Vlachos, Pinelopi, Engskog, Mikael K.R., Herrera, Antonio J., Espinosa-Oliva, Ana M., Joseph, Bertrand, Hajji, Nabil, Venero, José L., Burguillos, Miguel A.·2020·Cells
DOI 10.3390/cells9071717PMC PMC7407646
Open this paper in CoChat — free account

Abstract

The pro-inflammatory immune response driven by microglia is a key contributor to the pathogenesis of several neurodegenerative diseases. Though the research of microglia spans over a century, the last two decades have increased our understanding exponentially. Here, we discuss the phenotypic transformation from homeostatic microglia towards reactive microglia, initiated by specific ligand binding to pattern recognition receptors including toll-like receptor-4 (TLR4) or triggering receptors expressed on myeloid cells-2 (TREM2), as well as pro-inflammatory signaling pathways triggered such as the caspase-mediated immune response. Additionally, new research disciplines such as epigenetics and immunometabolism have provided us with a more holistic view of how changes in DNA methylation, microRNAs, and the metabolome may influence the pro-inflammatory response. This review aimed to discuss our current knowledge of pro-inflammatory microglia from different angles, including recent research highlights such as the role of exosomes in spreading neuroinflammation and emerging techniques in microglia research including positron emission tomography (PET) scanning and the use of human microglia generated from induced pluripotent stem cells (iPSCs). Finally, we also discuss current thoughts on the impact of pro-inflammatory microglia in neurodegenerative diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells9071717

Cites

411 of 411 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 TLR4 signaling pathways activated in microglia during neuroinflammation. (A) LPS binding to TLR4 triggers sequential activation of caspase-8 and caspase-3 with nuclear translocation of NF-κB and expression of genes involved in inflammatory response. The molecular mechanism triggering activation of caspase-8 is unknown at the moment. LPS can also activate the expression of inflammatory genes by means of (B) the MyD88-dependent pathway or (C) the TIR-domain containing adapter-inducing interferon-γ (TRIF)-dependent pathway with receptor-interacting protein kinase 1 (RIPK1) ubiquitination. (D) Although not clearly defined in microglia, under deubiquitinating conditions, RIPK1 can form a ripoptosome-like complex that ultimately leads to necrosome formation and necroptotic cell death with release of DAMPs. (E) TLR4-mediated increase in gene expression of NOD-, LRR- and pyrin domain-containing protein (NLRP3), pro-IL-1β, and pro-IL-18 is the priming stage of inflammasome formation. In the activation stage, the assembly of inflammasome complex activates caspase-1, which allows the maturation of IL-1β and IL-18 and their release through pyroptosis. (F) A noncanonical inflammasome has been also described in microglia that gives rise to caspase-8 activation and IL-1β maturation and release.
Figure 1 TLR4 signaling pathways activated in microglia during neuroinflammation. (A) LPS binding to TLR4 triggers sequential activation of caspase-8 and caspase-3 with nuclear translocation of NF-κB and expression of genes involved in inflammatory response. The molecular mechanism triggering activation of caspase-8 is unknown at the moment. LPS can also activate the expression of inflammatory genes by means of (B) the MyD88-dependent pathway or (C) the TIR-domain containing adapter-inducing interferon-γ (TRIF)-dependent pathway with receptor-interacting protein kinase 1 (RIPK1) ubiquitination. (D) Although not clearly defined in microglia, under deubiquitinating conditions, RIPK1 can form a ripoptosome-like complex that ultimately leads to necrosome formation and necroptotic cell death with release of DAMPs. (E) TLR4-mediated increase in gene expression of NOD-, LRR- and pyrin domain-containing protein (NLRP3), pro-IL-1β, and pro-IL-18 is the priming stage of inflammasome formation. In the activation stage, the assembly of inflammasome complex activates caspase-1, which allows the maturation of IL-1β and IL-18 and their release through pyroptosis. (F) A noncanonical inflammasome has been also described in microglia that gives rise to caspase-8 activation and IL-1β maturation and release.CC BY · PubMed Central
Figure 2 Schematic representation of epigenetic control of the inflammatory response in microglia. (A) SIRT1 deacetylates and activates DNMT1, provoking IL-1β repression through DNA methylation. TET2 regulates the expression of genes related to type I interferon response and glucose metabolism independently of its enzymatic activity, most likely acting as a scaffold for other proteins in gene promoter regions. (B) The histone methylase EZH2 and the histone demethylase JMJD3 increase or decrease the pro-inflammatory response respectively through H3K27 methylation/demethylation (once H3K27 is demethylated it becomes acetylated by CBP/P300). The use of HDACi such as TSA, VPA, SAHA, or SB, or the decrease in expression in HDAC1 and HDAC2 decreases the pro-inflammatory response and increases microglial phagocytic capacity. SIRT1 interacts with hMOF, resulting in the deacetylation and activation of hMOF, which then acetylates H4K16 and promotes the tumor-supportive microglial phenotype. (C) MiRs regulate the microglial inflammatory response. MiRs are transcribed and processed in the nucleus into pri-miR and pre-miR, which are then translocated to the cytosol with the aid of Ran-GTP/exportin 5. Once in the cytosol, pre-miR becomes miR through processing mediated by DICER/TRBP/AGO2. Finally, miR targets mRNA, forming a miRISC complex, which provokes either mRNA degradation or inhibits translation of the targeted genes. MiR-365, miR-125b and miR155 promote a pro-inflammatory response while miR-Let7a and miR-Let7c inhibit it. Also, miR-155 inhibits phagocytosis while miR-124 promotes it.
Figure 2 Schematic representation of epigenetic control of the inflammatory response in microglia. (A) SIRT1 deacetylates and activates DNMT1, provoking IL-1β repression through DNA methylation. TET2 regulates the expression of genes related to type I interferon response and glucose metabolism independently of its enzymatic activity, most likely acting as a scaffold for other proteins in gene promoter regions. (B) The histone methylase EZH2 and the histone demethylase JMJD3 increase or decrease the pro-inflammatory response respectively through H3K27 methylation/demethylation (once H3K27 is demethylated it becomes acetylated by CBP/P300). The use of HDACi such as TSA, VPA, SAHA, or SB, or the decrease in expression in HDAC1 and HDAC2 decreases the pro-inflammatory response and increases microglial phagocytic capacity. SIRT1 interacts with hMOF, resulting in the deacetylation and activation of hMOF, which then acetylates H4K16 and promotes the tumor-supportive microglial phenotype. (C) MiRs regulate the microglial inflammatory response. MiRs are transcribed and processed in the nucleus into pri-miR and pre-miR, which are then translocated to the cytosol with the aid of Ran-GTP/exportin 5. Once in the cytosol, pre-miR becomes miR through processing mediated by DICER/TRBP/AGO2. Finally, miR targets mRNA, forming a miRISC complex, which provokes either mRNA degradation or inhibits translation of the targeted genes. MiR-365, miR-125b and miR155 promote a pro-inflammatory response while miR-Let7a and miR-Let7c inhibit it. Also, miR-155 inhibits phagocytosis while miR-124 promotes it.CC BY · PubMed Central
Figure 3 Overview of metabolic alterations in microglia metabolic pathways associated with the four immunometabolites (yellow boxes): Itaconate, tryptophan, arginine, and glutamine in microglia. Metabolic changes in itaconate observed in macrophages and the TCA cycle (dotted line) include activation of NRF2/ATF3, inhibition of SDH as well as stabilization of HIF1α, production of IL-1β, and increased OxPHOS through succinate accumulation as well as inhibition of glycolysis through citrate. Tryptophan catabolism results in the conversion of tryptophan to kynurinene by IDO and the production of kynurenic acid or 3-hydroxykynurinene, the latter of which produces quinolinic acid with neurotoxic effects. Arginine catabolism is illustrated by either the generation of ornithine by ARG1, ultimately leading to polyamine production used for repair and wound healing, or production of citrulline and NO by NOS2. NO effectively inhibits OxPHOS. Glutamine results in mTOR activation and is converted to glutamate through GLS. Glutamate is further metabolized by GDH to form one of the principal components of the TCA cycle: α-ketoglutarate.
Figure 3 Overview of metabolic alterations in microglia metabolic pathways associated with the four immunometabolites (yellow boxes): Itaconate, tryptophan, arginine, and glutamine in microglia. Metabolic changes in itaconate observed in macrophages and the TCA cycle (dotted line) include activation of NRF2/ATF3, inhibition of SDH as well as stabilization of HIF1α, production of IL-1β, and increased OxPHOS through succinate accumulation as well as inhibition of glycolysis through citrate. Tryptophan catabolism results in the conversion of tryptophan to kynurinene by IDO and the production of kynurenic acid or 3-hydroxykynurinene, the latter of which produces quinolinic acid with neurotoxic effects. Arginine catabolism is illustrated by either the generation of ornithine by ARG1, ultimately leading to polyamine production used for repair and wound healing, or production of citrulline and NO by NOS2. NO effectively inhibits OxPHOS. Glutamine results in mTOR activation and is converted to glutamate through GLS. Glutamate is further metabolized by GDH to form one of the principal components of the TCA cycle: α-ketoglutarate.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 414 references

Research works printed but not linked: 7

  1. 1913, Contribución al Conocimiento de la Neuroglía del Cerebro Humano, Trab. Lab. Invest. Biol. Univ. Madrid, XI, 215
  2. 1920, Estudios sobre la neuroglía. La microglía y su transformación en células en bastoncito y cuerpos gránulo-adiposos, Trab. Lab. Invest. Biol. Univ. Madrid, 18, 37
  3. 1919, El “tercer elemento” de los centros nerviosos. I. La microglía en estado normal, Bol. Soc. Esp. Biol., VIII, 67
  4. 1919, El Tercer Elemento de los Centros Nerviosos. II. Intervención de la Microglía en los Procesos Patológicos (Células en Bastoncito y Cuerpos Gránuloadiposos), Bol. Soc. Esp. Biol., VIII, 91
  5. 1919, El “tercer elemento” de los centros nerviosos. III. Naturaleza probable de la microglía, Bol. Soc. Esp. Biol., VIII, 108
  6. 1919, El “tercer elemento de los centros nerviosos”. IV. Poder fagocitario y movilidad de la microglía, Bol. Soc. Esp. Biol., VIII, 154
  7. The National Academies of Sciences, Engineering and Medicine (2018). Biomarkers of Neuroinflammation—Proceedings of a Workshop, The National Academies Press.

Cited by

Sorted by citations

See all 365

Related

Metadata

Authors
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A.
Affiliations
  • Institute of Biomedicine of Seville (IBIS)-Hospital Universitario Virgen del Rocío/CSIC/University of Seville, 41012 Seville, Spain
  • Universidad de Sevilla (ES)
  • Institute of Environmental Medicine, Toxicology Unit, Karolinska Institute, 17177 Stockholm, Sweden
  • Uppsala University (SE)
  • Instituto de Biomedicina de Sevilla (ES)
  • Karolinska Institutet (SE)
  • Imperial College London (GB)
ORCID
Venue
Cells
Publisher
MDPI AG
Published
2020-07-17
Volume
9
Issue
7
Pages
1717
ISSN
2073-4409 (ISSN-L)
DOI
10.3390/cells9071717
PMC
PMC7407646
OpenAlex
W3043443440
Cited by
365
References
414
Citations by year
2026: 40 · 2025: 80 · 2024: 69 · 2023: 54 · 2022: 71 · 2021: 41 · 2020: 9
FWCI
4.38
Type
journal article
Language
en
Open access
Licence
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, cc-by-nc-nd)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Ministerio de Ciencia, Innovación y Universidades /FEDER/UE (RTI2018-098645-B-100)
  • FEDER I+D+i-USE (US-1265062)
  • Ministerio de Economia y Competitividad (Programa Ramón y Cajal: RYC-2017-21804)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
microglia, neuroinflammation, reactive microglia, homeostatic microglia, pattern recognition receptors, TLR4, TREM2, epigenetics, DNA methylation, microRNA, immunometabolism, exosomes, neurodegenerative diseases, iPSC-derived microglia
MeSH terms
Animals, Central Nervous System, Humans, Inflammation, Models, Biological, Microglia, Caspases, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review